Literature DB >> 32815626

Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae isolates.

Yumi Park1,2,3, Qute Choi1, Gye Cheol Kwon1, Sun Hoe Koo1.   

Abstract

BACKGROUND: The emergence and transmission of tigecycline- and carbapenem-resistant Klebsiella pneumoniae (TCRKP) have become a major concern to public health globally. Here, we investigated the molecular epidemiology and mechanisms of tigecycline resistance in carbapenem-resistant K pneumoniae (CRKP) isolates.
METHODS: Forty-five non-duplicate CRKP isolates were collected from January 2017 to June 2019. We performed antimicrobial susceptibility tests, multilocus sequence typing (MLST), and pulsed-field gel electrophoresis (PFGE). PCR and DNA sequencing were performed for the detection and mutation analysis of acrR, oqxR, ramR, rpsJ, tet(A), and tet(X) genes, which are related to tigecycline resistance. The expression levels of efflux pump genes acrB and oqxB and their regulator genes rarA, ramA, soxS, and marA were assessed by quantitative real-time PCR.
RESULTS: The resistance rate to tigecycline in CRKP isolates was 37.8% (17/45). K pneumoniae ST307 was a predominant clone type (70.6%, 12/17) among the TCRKP isolates. The expression levels of acrB (P < .001) and marA (P = .009) were significantly higher in the tigecycline-resistant group than in the tigecycline-intermediate and tigecycline-susceptible groups. Increased expression of acrB was associated with marA expression (r = 0.59, P = .013).
CONCLUSIONS: We found that the activated MarA-induced overexpression of AcrAB efflux pump plays an important role in the emergence of tigecycline resistance in CRKP isolates.
© 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals LLC.

Entities:  

Keywords:  AcrAB-TolC efflux pump; carbapenem-resistant Klebsiella pneumoniae; tigecycline resistance

Mesh:

Substances:

Year:  2020        PMID: 32815626      PMCID: PMC7755817          DOI: 10.1002/jcla.23506

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   3.124


  36 in total

1.  Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae.

Authors:  Alexey Ruzin; Melissa A Visalli; David Keeney; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment.

Authors:  Fang He; Qiucheng Shi; Ying Fu; Juan Xu; Yunsong Yu; Xiaoxing Du
Journal:  Infect Genet Evol       Date:  2018-09-27       Impact factor: 3.342

3.  Tigecycline is modified by the flavin-dependent monooxygenase TetX.

Authors:  Ian F Moore; Donald W Hughes; Gerard D Wright
Journal:  Biochemistry       Date:  2005-09-06       Impact factor: 3.162

4.  Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).

Authors:  Helio S Sader; Mariana Castanheira; Robert K Flamm; Rodrigo E Mendes; David J Farrell; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2015-06-23       Impact factor: 2.803

5.  Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.

Authors:  Subhasree Roy; Saswati Datta; Rajlakshmi Viswanathan; Arun K Singh; Sulagna Basu
Journal:  J Antimicrob Chemother       Date:  2013-01-18       Impact factor: 5.790

6.  Optimization of pulse-field gel electrophoresis for subtyping of Klebsiella pneumoniae.

Authors:  Hui Han; Haijian Zhou; Haishan Li; Yuan Gao; Zhi Lu; Kongxin Hu; Baoliang Xu
Journal:  Int J Environ Res Public Health       Date:  2013-07-01       Impact factor: 3.390

7.  Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.

Authors:  Fang He; Ying Fu; Qiong Chen; Zhi Ruan; Xiaoting Hua; Hua Zhou; Yunsong Yu
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

8.  Development of Tigecycline Resistance in Carbapenemase-Producing Klebsiella pneumoniae Sequence Type 147 via AcrAB Overproduction Mediated by Replacement of the ramA Promoter.

Authors:  Eun Jeong Yoon; Yena Oh; Seok Hoon Jeong
Journal:  Ann Lab Med       Date:  2020-01       Impact factor: 3.464

9.  Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.

Authors:  Mary L Townsend; Melanie W Pound; Richard H Drew
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

Review 10.  Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants.

Authors:  Paula Blanco; Sara Hernando-Amado; Jose Antonio Reales-Calderon; Fernando Corona; Felipe Lira; Manuel Alcalde-Rico; Alejandra Bernardini; Maria Blanca Sanchez; Jose Luis Martinez
Journal:  Microorganisms       Date:  2016-02-16
View more
  5 in total

1.  Comparison of Carbapenem-Resistant Klebsiella pneumoniae Strains Causing Intestinal Colonization and Extraintestinal Infections: Clinical, Virulence, and Molecular Epidemiological Characteristics.

Authors:  Wenli Liao; Na Huang; Ying Zhang; Yao Sun; Tao Chen; Weiliang Zeng; Liqiong Chen; Hong Wen; Jianming Cao; Tieli Zhou
Journal:  Front Public Health       Date:  2021-12-03

2.  Evaluation of in vivo antibacterial drug efficacy using Caenorhabditis elegans infected with carbapenem-resistant Klebsiella pneumoniae as a model host.

Authors:  Huijuan Yao; Ajing Xu; Jingxian Liu; Fang Wang; Huimin Yao; Jihui Chen
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

3.  TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia.

Authors:  Xiaojuan Wang; Xiaoling Xu; Shaojun Zhang; Na Chen; Yunfeng Sun; Kuifen Ma; Dongsheng Hong; Lu Li; Yongzhong Du; Xiaoyang Lu; Saiping Jiang
Journal:  Nat Commun       Date:  2022-06-29       Impact factor: 17.694

4.  Epidemiology, Susceptibility, and Risk Factors Associated with Mortality in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Abdominal Solid Organ Transplant Recipients: A Retrospective Cohort Study.

Authors:  Di Wu; Chunmei Chen; Taohua Liu; Yan Jia; Qiquan Wan; Jie Peng
Journal:  Infect Dis Ther       Date:  2021-02-21

5.  Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae isolates.

Authors:  Yumi Park; Qute Choi; Gye Cheol Kwon; Sun Hoe Koo
Journal:  J Clin Lab Anal       Date:  2020-08-20       Impact factor: 3.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.